Zen finds clue on $APRI

Seems like a buyout potential is in the card giving the clue I find here:

Apricus Biosciences Inc (NASDAQ:APRI) Investor Alert: Investigation on Potential Takeover

An investigation on behalf of investors of Apricus Biosciences Inc (NASDAQ:APRI) in connection with a potential takeover was announced and NASDAQ:APRI stockholders should contact the Shareholders Foundation.

Repost This

San Diego, CA — (SBWIRE) — 05/21/2013 — An investigation on behalf of investors, who currently hold NASDAQ:APRI shares, was announced concerning whether a takeover of Apricus Biosciences Inc would be unfair.

Investors who purchased shares of the Apricus Biosciences Inc (NASDAQ:APRI) and currently hold any of those NASDAQ:APRI shares have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm is at an early stage and concerns whether a potential takeover would be unfair to NASDAQ:APRI investors.

On May 14, 2013, Apricus Biosciences Inc disclosed that on May 14, 2013, the Board of Directors of Apricus Biosciences, Inc. voted to terminate Apricus Biosciences’ Shareholder Rights Agreement dated as of March 22, 2011, by and between Apricus Biosciences and Wells Fargo Bank, N.A., as rights agent.

Shares of Apricus Biosciences grew from $2.50 on May 14, 2013, to $3.409 on May 20, 2013.

However, given that NASDAQ:APRI shares traded in early 2012 as high as $5.49 and that at least one analyst has set the high target price for Apricus Biosciences shares at $8.00 per share, the investigation by a law firm concerns whether the Apricus Biosciences Board of Directors will undertake an adequate sales process, adequately shop the company before entering into any transaction, maximize shareholder value by negotiating the best price, and act in the shareholders’ best interests in connection with the proposed sale.

Shares of Apricus Biosciences Inc closed on May 20, 2013, at $3.35 per share.

Those who are current investors in Apricus Biosciences Inc (NASDAQ:APRI) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Joelle Day
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

Media Relations Contact

Joelle Day
Media and Client Relations Manager
Shareholders Foundation, Inc.
858-779-1554
Email

Follow Shareholders Foundation, Inc.:

Shareholders Foundation, Inc. – Logo

Logo

Disclaimer: I’m not familiar with Shareholders Foundation, Inc., so you have to take this piece of information at face value.

Nevertheless, I added more because price took out the high of Feb 11th again.

Click here for link to the article above.

Click here for link to Shareholders Foundation Inc.’s page on Apricus Biosciences, Inc.

My 2 cents.



Categories: APRI

Tags: , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: